Glaukos Corporation

GKOS Healthcare Medical Devices

Glaukos Corporation’s revenue for fiscal 2025 (year ended December 2025) was $507.4 million, up 32.3% from fiscal 2024. In the quarter to June 2026, revenue grew 49.5%, EPS grew 8.82%, free cash flow grew 211.8% and total debt fell 2.15%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

164.84 0.76 −0.46%
Market cap
$9.8B
P/E
0.0×
Fwd P/E
−139×
Dividend yield
—
F-score
3/9
Altman Z
15.20
Beneish M
−2.96
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
9.96 12.73 11.33 13.41
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(463.91) 943.64 (498.69) 554.57
P/B ratio
6.08 9.84 9.31 12.04
Price to Tangible BV
10.67 14.43 13.26 16.82
EV/Sales
10.12 12.86 11.46 13.51
EV/EBITDA
0.00 0.00 0.00 0.00
EV/Operating CF
(225.08) (441.27) (718.34) (8,716.70)
EV/FCF
(107.54) (167.07) (180.03) (678.98)
Quick Ratio
4.26 3.82 4.43 4.15
Current Ratio
5.20 4.69 5.43 5.04
Net Debt/EBITDA
30.75 1.66 29.18 30.16
Debt/Assets
6.85% 7.62% 7.58% 7.32%
Debt/Equity
0.09 0.10 0.10 0.10
Asset Turnover
0.49 0.54 0.59 0.64
Operating CF/Net income
0.62 (0.05) 0.63 (0.81)
Capex/Depreciation
(0.17) (0.23) (0.31) (0.27)
Interest Coverage
(13.93) (122.05) (17.65) (11.83)
Research and Development Expense of Revenue
28.51% 30.50% 29.32% 28.45%
Selling, General and Administrative Expense of Revenue
62.15% 66.17% 61.73% 62.53%
Intangible Assets out of Total Assets
0.33 0.23 0.22 0.21
Share Based Compensation of Revenue
11.17% 12.09% 12.71% 15.55%
Graham Net Nets
0.05 0.04 0.04 0.03
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(1.89%) (2.89%) (3.05%) (2.33%)
Free Cash Flow Yield
(0.94%) (0.60%) (0.56%) (0.15%)
Revenue per Share
2.33 2.50 2.60 3.16
Operating CF per Share
(0.18) 0.12 (0.22) 0.25
Capex per Share
(0.03) (0.05) (0.07) (0.05)
Free Cash Flow per Share
(0.20) 0.07 (0.28) 0.21
Cash per Share
4.77 4.87 4.77 4.87
Shareholders Equity per Share
13.41 11.47 11.56 11.60
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
13.41 11.47 11.56 11.60
Free Cash Flow
(11.72) 3.93 (16.48) 12.09
Working Capital
367.25 373.71 396.34 413.45
Capital Expenditures
(1.63) (2.91) (3.96) (2.74)
Net Current Asset Value
224.93 237.65 263.36 277.74
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.01 0.02 0.03 0.01
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
77.55 84.68 95.61 110.94
Average Payables
15.49 18.83 17.49 16.41
Average Inventory
61.88 60.62 60.92 61.96
Average Assets
962.96 934.12 929.75 953.74
Average Common Equity
719.03 711.54 717.44 723.80

Fold the line items

Columns are period end dates